Given the potential for direct binding between CHMP7 and CHMP2B (Supplemental Fig. S13), our study also suggests the possibility that small molecule inhibitors of sustained nuclear CHMP7 – CHMP2B interactions may be a future alternative therapeutic approach to alleviate NPC injury cascades in disease. The gene discussed is CHMP7; the disease is nasopharyngeal carcinoma.